Global gene expression profiles in skeletal muscle of monozygotic female twins discordant for hormone replacement therapy

Aging Cell

Volumn 9, Issue 6, 2010, Pages 1098-1110

  Ronkainen, Paula H A ^a   Pöllänen, Eija ^a   Alén, Markku ^b,c   Pitkänen, Reino ^d   Puolakka, Jukka ^d   Kujala, Urho M ^a   Kaprio, Jaakko ^e,f   Sipilä, Sarianna ^a   Kovanen, Vuokko ^a  

^a UNIVERSITY OF JYVÄSKYLÄ   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d Central Finland Central Hospital   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Aging; Hormone replacement therapy; Postmenopause; Skeletal muscle; Transcriptome; Twin design

Indexed keywords

ESTRADIOL; ESTROGEN; GESTAGEN; TRANSCRIPTOME;

ADULT; ARTICLE; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; FEMALE; GENE EXPRESSION PROFILING; HUMAN; MONOZYGOTIC TWINS; MUSCLE FUNCTION; POSTMENOPAUSE; PRIORITY JOURNAL; SKELETAL MUSCLE; TWIN DISCORDANCE; UPREGULATION;

COHORT STUDIES; DNA COPY NUMBER VARIATIONS; DNA, MITOCHONDRIAL; DOWN-REGULATION; ESTROGEN REPLACEMENT THERAPY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; MUSCLE, SKELETAL; SUCCINATE DEHYDROGENASE; TWINS, MONOZYGOTIC;

EID: 78249272958     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2010.00636.x     Document Type: Article

References (84)

1. Abbot EL, McCormack JG, Reynet C, Hassall DG, Buchan KW, Yeaman SJ (2005) Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells. FEBS J. 272, 3004-3014.
2. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S, Women's Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291, 1701-1712.
3. Ankarberg-Lindgren C, Norjavaara E (2008) A purification step prior to commercial sensitive immunoassay is necessary to achieve clinical usefulness when quantifying serum 17beta-estradiol in prepubertal children. Eur. J. Endocrinol. 158, 117-124.
4. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O'Rahilly S (1999) Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402, 880-883.
5. Bishop AL, Hall A (2000) Rho GTPases and their effector proteins. Biochem. J. 348(Pt 2), 241-255.
6. Bjornerem A, Straume B, Midtby M, Fonnebo V, Sundsfjord J, Svartberg J, Acharya G, Oian P, Berntsen GK (2004) Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromso Study. J. Clin. Endocrinol. Metab. 89, 6039-6047.
7. Bouchard C, Tremblay A, Despres JP, Nadeau A, Lupien PJ, Theriault G, Dussault J, Moorjani S, Pinault S, Fournier G (1990) The response to long-term overfeeding in identical twins. N. Engl. J. Med. 322, 1477-1482.
8. Bowker-Kinley MM, Davis WI, Wu P, Harris RA, Popov KM (1998) Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem. J. 329(Pt 1), 191-196.
9. Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, Rando TA (2007) Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317, 807-810.
10. Calles-Escandon J, Arciero PJ, Gardner AW, Bauman C, Poehlman ET (1995) Basal fat oxidation decreases with aging in women. J. Appl. Physiol. 78, 266-271.
11. Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY (2008) Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 336, 1227-1231.
12. Chen JQ, Cammarata PR, Baines CP, Yager JD (2009) Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim. Biophys. Acta 1793, 1540-1570.
13. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207-210.
14. Ettinger AJ, Feng G, Sanes JR (1997) epsilon-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J. Biol. Chem. 272, 32534-32538.
15. Evans RM, Barish GD, Wang YX (2004) PPARs and the complex journey to obesity. Nat. Med. 10, 355-361.
16. Gallo R, Serafini M, Castellani L, Falcone G, Alema S (1999) Distinct effects of Rac1 on differentiation of primary avian myoblasts. Mol. Biol. Cell 10, 3137-3150.
17. Gautier L, Cope L, Bolstad BM, Irizarry RA (2004) affy - analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307-315.
18. Greising SM, Baltgalvis KA, Lowe DA, Warren GL (2009) Hormone therapy and skeletal muscle strength: a meta-analysis. J. Gerontol. A Biol. Sci. Med. Sci. 64, 1071-1081.
19. Grodstein F, Newcomb PA, Stampfer MJ (1999) Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am. J. Med. 106, 574-582.
20. Heron L, Virsolvy A, Peyrollier K, Gribble FM, Le Cam A, Ashcroft FM, Bataille D (1998) Human alpha-endosulfine, a possible regulator of sulfonylurea-sensitive KATP channel: molecular cloning, expression and biological properties. Proc. Natl. Acad. Sci. U.S.A. 95, 8387-8391.
21. Hirai M, Ohbayashi T, Horiguchi M, Okawa K, Hagiwara A, Chien KR, Kita T, Nakamura T (2007) Fibulin-5/DANCE has an elastogenic organizer activity that is abrogated by proteolytic cleavage in vivo. J. Cell Biol. 176, 1061-1071.
22. Kallman DA, Plato CC, Tobin JD (1990) The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. J. Gerontol. 45, M82-M88.
23. Kaprio J, Koskenvuo M (2002) Genetic and environmental factors in complex diseases: the older Finnish Twin Cohort. Twin Res. 5, 358-365.
24. Kidd T, Brose K, Mitchell KJ, Fetter RD, Tessier-Lavigne M, Goodman CS, Tear G (1998) Roundabout controls axon crossing of the CNS midline and defines a novel subfamily of evolutionarily conserved guidance receptors. Cell 92, 205-215.
25. Kublickiene K, Fu XD, Svedas E, Landgren BM, Genazzani AR, Simoncini T (2008) Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement. J. Clin. Endocrinol. Metab. 93, 1874-1883.
26. Laustiola KE, Lassila R, Kaprio J, Koskenvuo M (1988) Decreased betaadrenergic receptor density and catecholamine response in male cigarette smokers. A study of monozygotic twin pairs discordant for smoking. Circulation 78, 1234-1240.
27. Lemoine S, Granier P, Tiffoche C, Rannou-Bekono F, Thieulant ML, Delamarche P (2003) Estrogen receptor alpha mRNA in human skeletal muscles. Med. Sci. Sports Exerc. 35, 439-443.
28. Leskinen T, Sipilä S, Alen M, Cheng S, Pietiläinen KH, Usenius JP, Suominen H, Kovanen V, Kainulainen H, Kaprio J, Kujala UM (2009) Leisure-time physical activity and high-risk fat: a longitudinal population-based twin study. Int. J. Obes. (Lond.) 11, 1211-1218.
29. Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-Hardy K, Paul Murphy M, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin WL, Yen SH, Dickson DW, Davies P, Hutton M (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25, 402-405.
30. Luo L, Liao YJ, Jan LY, Jan YN (1994) Distinct morphogenetic functions of similar small GTPases: Drosophila Drac1 is involved in axonal outgrowth and myoblast fusion. Genes Dev. 8, 1787-1802.
31. MacLennan A, Lester S, Moore V (2001) Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric 4, 58-74.
32. Madsen KL, Tavernini MM, Yachimec C, Mendrick DL, Alfonso PJ, Buergin M, Olsen HS, Antonaccio MJ, Thomson AB, Fedorak RN (1998) Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestine. Am. J. Physiol. 274, G96-G102.
33. McKinlay SM, Brambilla DJ, Posner JG (1992) The normal menopause transition. Maturitas 14, 103-115.
34. Melov S, Tarnopolsky MA, Beckman K, Felkey K, Hubbard A (2007) Resistance exercise reverses aging in human skeletal muscle. PLoS ONE 2, e465.
35. Meriane M, Roux P, Primig M, Fort P, Gauthier-Rouviere C (2000) Critical activities of Rac1 and Cdc42Hs in skeletal myogenesis: antagonistic effects of JNK and p38 pathways. Mol. Biol. Cell 11, 2513-2528.
36. Milanesi L, Russo de Boland A, Boland R (2008) Expression and localization of estrogen receptor alpha in the C2C12 murine skeletal muscle cell line. J. Cell. Biochem. 104, 1254-1273.
37. Nader GA (2005) Molecular determinants of skeletal muscle mass: getting the "AKT" together. Int. J. Biochem. Cell Biol. 37, 1985-1996.
38. Nakamura T, Lozano PR, Ikeda Y, Iwanaga Y, Hinek A, Minamisawa S, Cheng CF, Kobuke K, Dalton N, Takada Y, Tashiro K, Ross Jr J, Honjo T, Chien KR (2002) Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 415, 171-175.
39. Nanda K, Bastian LA, Hasselblad V, Simel DL (1999) Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstet. Gynecol. 93, 880-888.
40. Nelson RE, Grebe SK, OKane DJ, Singh RJ (2004) Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin. Chem. 50, 373-384.
41. Notelovitz M, Lenihan JP, McDermott M, Kerber IJ, Nanavati N, Arce J (2000) Initial 17beta-estradiol dose for treating vasomotor symptoms. Obstet. Gynecol. 95, 726-731.
42. Pette D, Tyler KR (1983) Response of succinate dehydrogenase activity in fibres of rabbit tibialis anterior muscle to chronic nerve stimulation. J. Physiol. 338, 1-9.
43. Phillips SK, Rook KM, Siddle NC, Bruce SA, Woledge RC (1993) Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin. Sci. (Lond.) 84, 95-98.
44. Pietiläinen KH, Naukkarinen J, Rissanen A, Saharinen J, Ellonen P, Keränen H, Suomalainen A, Gotz A, Suortti T, Yki-Järvinen H, Oresic M, Kaprio J, Peltonen L (2008) Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med. 5, e51.
45. Pöllänen E, Ronkainen PHA, Suominen H, Takala T, Koskinen S, Puolakka J, Sipilä S, Kovanen V (2007) Muscular transcriptome in postmenopausal women with or without hormone replacement. Rejuvenation Res. 10, 485-500.
46. Pöllänen E, Fey V, Törmäkangas T, Ronkainen PHA, Taaffe DR, Takala T, Koskinen S, Cheng S, Puolakka J, Kujala UM, Suominen H, Sipilä S, Kovanen V (2010) Power training and postmenopausal hormone therapy affect transcriptional control of specific co-regulated gene clusters in skeletal muscle. Age 32, 347-363.
47. Priestman DA, Mistry SC, Kerbey AL, Randle PJ (1992) Purification and partial characterization of rat liver pyruvate dehydrogenase kinase activator protein (free pyruvate dehydrogenase kinase). FEBS Lett. 308, 83-86.
48. Randle PJ (1986) Fuel selection in animals. Biochem. Soc. Trans. 14, 799-806.
49. Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, Curb JD, White L (1999) Midlife hand grip strength as a predictor of old age disability. JAMA 281, 558-560.
50. Rantanen T, Volpato S, Ferrucci L, Heikkinen E, Fried LP, Guralnik JM (2003) Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J. Am. Geriatr. Soc. 51, 636-641.
51. Rome S, Clement K, Rabasa-Lhoret R, Loizon E, Poitou C, Barsh GS, Riou JP, Laville M, Vidal H (2003) Microarray profiling of human skeletal muscle reveals that insulin regulates approximately 800 genes during a hyperinsulinemic clamp. J. Biol. Chem. 278, 18063-18068.
52. Ronkainen PHA, Kovanen V, Alen M, Pöllänen E, Palonen EM, Ankarberg-Lindgren C, Hamalainen E, Turpeinen U, Kujala UM, Puolakka J, Kaprio J, Sipilä S (2009) Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs. J. Appl. Physiol. 107, 25-33.
53. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333.
54. Roth SM, Ferrell RE, Peters DG, Metter EJ, Hurley BF, Rogers MA (2002) Influence of age, sex, and strength training on human muscle gene expression determined by microarray. Physiol. Genomics 10, 181-190.
55. Samson MM, Meeuwsen IB, Crowe A, Dessens JA, Duursma SA, Verhaar HJ (2000) Relationships between physical performance measures, age, height and body weight in healthy adults. Age Ageing 29, 235-242.
56. Sare GM, Gray LJ, Bath PM (2008) Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. Eur. Heart J. 29, 2031-2041.
57. Simoncini T, Scorticati C, Mannella P, Fadiel A, Giretti MS, Fu XD, Baldacci C, Garibaldi S, Caruso A, Fornari L, Naftolin F, Genazzani AR (2006) Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway. Mol. Endocrinol. 20, 1756-1771.
58. Sipilä S, Taaffe DR, Cheng S, Puolakka J, Toivanen J, Suominen H (2001) Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin. Sci. (Lond.) 101, 147-157.
59. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3.
60. Spiegelman BM (1998) PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47, 507-514.
61. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156, 1051-1063.
62. Stearns V, Ullmer L, Lopez JF, Smith Y, Isaacs C, Hayes D (2002) Hot flushes. Lancet 360, 1851-1861.
63. Stephens NA, Gallagher IJ, Rooyackers O, Skipworth RJ, Tan BH, Marstrand T, Ross JA, Guttridge DC, Lundell L, Fearon KC, Timmons JA (2010) Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia. Genome Med. 2, 1.
64. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545-15550.
65. Taaffe DR, Sipilä S, Cheng S, Puolakka J, Toivanen J, Suominen H (2005) The effect of hormone replacement therapy and/or exercise on skeletal muscle attenuation in postmenopausal women: a yearlong intervention. Clin. Physiol. Funct. Imaging 25, 297-304.
66. Takano H, Komuro I, Oka T, Shiojima I, Hiroi Y, Mizuno T, Yazaki Y (1998) The Rho family G proteins play a critical role in muscle differentiation. Mol. Cell. Biol. 18, 1580-1589.
67. Thalacker-Mercer AE, Fleet JC, Craig BA, Carnell NS, Campbell WW (2007) Inadequate protein intake affects skeletal muscle transcript profiles in older humans. Am. J. Clin. Nutr. 85, 1344-1352.
68. Tontonoz P, Spiegelman BM (2008) Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem. 77, 289-312.
69. Tontonoz P, Hu E, Spiegelman BM (1994) Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79, 1147-1156.
70. Torgerson DJ, Bell-Syer SE (2001) Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials. BMC Musculoskelet. Disord. 2, 7.
71. Tucker MZ, Turcotte LP (2002) Impaired fatty acid oxidation in muscle of aging rats perfused under basal conditions. Am. J. Physiol. Endocrinol. Metab. 282, E1102-E1109.
72. Turpeinen U, Linko S, Itkonen O, Hämäläinen E (2008) Determination of testosterone in serum by liquid chromatography-tandem mass spectrometry. Scand. J. Clin. Lab. Invest. 68, 50-57.
73. Vasconsuelo A, Milanesi L, Boland R (2008) 17Beta-estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway. J. Endocrinol. 196, 385-397.
74. Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84, 3666-3672.
75. Wagner GF, Gellersen B, Friesen HG (1989) Primary culture of teleocalcin cells from rainbow trout corpuscles of Stannius: regulation of teleocalcin secretion by calcium. Mol. Cell. Endocrinol. 62, 31-39.
76. Way JM, Harrington WW, Brown KK, Gottschalk WK, Sundseth SS, Mansfield TA, Ramachandran RK, Willson TM, Kliewer SA (2001) Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues. Endocrinology 142, 1269-1277.
77. Welle S, Brooks AI, Delehanty JM, Needler N, Thornton CA (2003) Gene expression profile of aging in human muscle. Physiol. Genomics 14, 149-159.
78. Welle S, Brooks AI, Delehanty JM, Needler N, Bhatt K, Shah B, Thornton CA (2004) Skeletal muscle gene expression profiles in 20-29-year old and 65-71-year old women. Exp. Gerontol. 39, 369-377.
79. Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N, Robinson V, Henry D, O'Connell D, Cranney A, Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group (2002) Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr. Rev. 23, 529-539.
80. Wiik A, Glenmark B, Ekman M, Esbjornsson-Liljedahl M, Johansson O, Bodin K, Enmark E, Jansson E (2003) Oestrogen receptor beta is expressed in adult human skeletal muscle both at the mRNA and protein level. Acta Physiol. Scand. 179, 381-387.
81. Yanagisawa H, Davis EC, Starcher BC, Ouchi T, Yanagisawa M, Richardson JA, Olson EN (2002) Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 415, 168-171.
82. Zahn JM, Sonu R, Vogel H, Crane E, Mazan-Mamczarz K, Rabkin R, Davis RW, Becker KG, Owen AB, Kim SK (2006) Transcriptional profiling of aging in human muscle reveals a common aging signature. PLoS Genet. 2, e115.
83. Zambon AC, McDearmon EL, Salomonis N, Vranizan KM, Johansen KL, Adey D, Takahashi JS, Schambelan M, Conklin BR (2003) Time-and exercise-dependent gene regulation in human skeletal muscle. Genome Biol. 4, R61.
84. Zurlo F, Larson K, Bogardus C, Ravussin E (1990) Skeletal muscle metabolism is a major determinant of resting energy expenditure. J. Clin. Invest. 86, 1423-1427.